Computational Medicine and Drug Designing Software Market
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Computational Medicine and Drug Designing Software Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Local Deployment
1.2.3 Cloud Deployment
1.3 Market by Application
1.3.1 Global Computational Medicine and Drug Designing Software Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Drug Discovery And Development
1.3.3 Computational Physiological Medicine
1.3.4 Disease Modeling
1.3.5 Medical Imaging
1.3.6 Predictive Analysis Of Drug Targets
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Computational Medicine and Drug Designing Software Market Perspective (2017-2028)
2.2 Computational Medicine and Drug Designing Software Growth Trends by Region
2.2.1 Computational Medicine and Drug Designing Software Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Computational Medicine and Drug Designing Software Historic Market Size by Region (2017-2022)
2.2.3 Computational Medicine and Drug Designing Software Forecasted Market Size by Region (2023-2028)
2.3 Computational Medicine and Drug Designing Software Market Dynamics
2.3.1 Computational Medicine and Drug Designing Software Industry Trends
2.3.2 Computational Medicine and Drug Designing Software Market Drivers
2.3.3 Computational Medicine and Drug Designing Software Market Challenges
2.3.4 Computational Medicine and Drug Designing Software Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Computational Medicine and Drug Designing Software Players by Revenue
3.1.1 Global Top Computational Medicine and Drug Designing Software Players by Revenue (2017-2022)
3.1.2 Global Computational Medicine and Drug Designing Software Revenue Market Share by Players (2017-2022)
3.2 Global Computational Medicine and Drug Designing Software Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Computational Medicine and Drug Designing Software Revenue
3.4 Global Computational Medicine and Drug Designing Software Market Concentration Ratio
3.4.1 Global Computational Medicine and Drug Designing Software Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Computational Medicine and Drug Designing Software Revenue in 2021
3.5 Computational Medicine and Drug Designing Software Key Players Head office and Area Served
3.6 Key Players Computational Medicine and Drug Designing Software Product Solution and Service
3.7 Date of Enter into Computational Medicine and Drug Designing Software Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Computational Medicine and Drug Designing Software Breakdown Data by Type
4.1 Global Computational Medicine and Drug Designing Software Historic Market Size by Type (2017-2022)
4.2 Global Computational Medicine and Drug Designing Software Forecasted Market Size by Type (2023-2028)
5 Computational Medicine and Drug Designing Software Breakdown Data by Application
5.1 Global Computational Medicine and Drug Designing Software Historic Market Size by Application (2017-2022)
5.2 Global Computational Medicine and Drug Designing Software Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Computational Medicine and Drug Designing Software Market Size (2017-2028)
6.2 North America Computational Medicine and Drug Designing Software Market Size by Country (2017-2022)
6.3 North America Computational Medicine and Drug Designing Software Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Computational Medicine and Drug Designing Software Market Size (2017-2028)
7.2 Europe Computational Medicine and Drug Designing Software Market Size by Country (2017-2022)
7.3 Europe Computational Medicine and Drug Designing Software Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Computational Medicine and Drug Designing Software Market Size (2017-2028)
8.2 Asia-Pacific Computational Medicine and Drug Designing Software Market Size by Country (2017-2022)
8.3 Asia-Pacific Computational Medicine and Drug Designing Software Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Computational Medicine and Drug Designing Software Market Size (2017-2028)
9.2 Latin America Computational Medicine and Drug Designing Software Market Size by Country (2017-2022)
9.3 Latin America Computational Medicine and Drug Designing Software Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Computational Medicine and Drug Designing Software Market Size (2017-2028)
10.2 Middle East & Africa Computational Medicine and Drug Designing Software Market Size by Country (2017-2022)
10.3 Middle East & Africa Computational Medicine and Drug Designing Software Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Entelos
11.1.1 Entelos Company Detail
11.1.2 Entelos Business Overview
11.1.3 Entelos Computational Medicine and Drug Designing Software Introduction
11.1.4 Entelos Revenue in Computational Medicine and Drug Designing Software Business (2017-2022)
11.1.5 Entelos Recent Development
11.2 Crown Bioscience
11.2.1 Crown Bioscience Company Detail
11.2.2 Crown Bioscience Business Overview
11.2.3 Crown Bioscience Computational Medicine and Drug Designing Software Introduction
11.2.4 Crown Bioscience Revenue in Computational Medicine and Drug Designing Software Business (2017-2022)
11.2.5 Crown Bioscience Recent Development
11.3 Chemical Computing Group
11.3.1 Chemical Computing Group Company Detail
11.3.2 Chemical Computing Group Business Overview
11.3.3 Chemical Computing Group Computational Medicine and Drug Designing Software Introduction
11.3.4 Chemical Computing Group Revenue in Computational Medicine and Drug Designing Software Business (2017-2022)
11.3.5 Chemical Computing Group Recent Development
11.4 Nimbus Therapeutics
11.4.1 Nimbus Therapeutics Company Detail
11.4.2 Nimbus Therapeutics Business Overview
11.4.3 Nimbus Therapeutics Computational Medicine and Drug Designing Software Introduction
11.4.4 Nimbus Therapeutics Revenue in Computational Medicine and Drug Designing Software Business (2017-2022)
11.4.5 Nimbus Therapeutics Recent Development
11.5 Schrodinger
11.5.1 Schrodinger Company Detail
11.5.2 Schrodinger Business Overview
11.5.3 Schrodinger Computational Medicine and Drug Designing Software Introduction
11.5.4 Schrodinger Revenue in Computational Medicine and Drug Designing Software Business (2017-2022)
11.5.5 Schrodinger Recent Development
11.6 Dassault Systemes
11.6.1 Dassault Systemes Company Detail
11.6.2 Dassault Systemes Business Overview
11.6.3 Dassault Systemes Computational Medicine and Drug Designing Software Introduction
11.6.4 Dassault Systemes Revenue in Computational Medicine and Drug Designing Software Business (2017-2022)
11.6.5 Dassault Systemes Recent Development
11.7 Genedata
11.7.1 Genedata Company Detail
11.7.2 Genedata Business Overview
11.7.3 Genedata Computational Medicine and Drug Designing Software Introduction
11.7.4 Genedata Revenue in Computational Medicine and Drug Designing Software Business (2017-2022)
11.7.5 Genedata Recent Development
11.8 Biognos
11.8.1 Biognos Company Detail
11.8.2 Biognos Business Overview
11.8.3 Biognos Computational Medicine and Drug Designing Software Introduction
11.8.4 Biognos Revenue in Computational Medicine and Drug Designing Software Business (2017-2022)
11.8.5 Biognos Recent Development
11.9 Leadscope
11.9.1 Leadscope Company Detail
11.9.2 Leadscope Business Overview
11.9.3 Leadscope Computational Medicine and Drug Designing Software Introduction
11.9.4 Leadscope Revenue in Computational Medicine and Drug Designing Software Business (2017-2022)
11.9.5 Leadscope Recent Development
11.10 Rhenovia Pharma Limited
11.10.1 Rhenovia Pharma Limited Company Detail
11.10.2 Rhenovia Pharma Limited Business Overview
11.10.3 Rhenovia Pharma Limited Computational Medicine and Drug Designing Software Introduction
11.10.4 Rhenovia Pharma Limited Revenue in Computational Medicine and Drug Designing Software Business (2017-2022)
11.10.5 Rhenovia Pharma Limited Recent Development
11.11 Compugen
11.11.1 Compugen Company Detail
11.11.2 Compugen Business Overview
11.11.3 Compugen Computational Medicine and Drug Designing Software Introduction
11.11.4 Compugen Revenue in Computational Medicine and Drug Designing Software Business (2017-2022)
11.11.5 Compugen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Computational Medicine and Drug Designing Software Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Local Deployment
Table 3. Key Players of Cloud Deployment
Table 4. Global Computational Medicine and Drug Designing Software Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global Computational Medicine and Drug Designing Software Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Computational Medicine and Drug Designing Software Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Computational Medicine and Drug Designing Software Market Share by Region (2017-2022)
Table 8. Global Computational Medicine and Drug Designing Software Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Computational Medicine and Drug Designing Software Market Share by Region (2023-2028)
Table 10. Computational Medicine and Drug Designing Software Market Trends
Table 11. Computational Medicine and Drug Designing Software Market Drivers
Table 12. Computational Medicine and Drug Designing Software Market Challenges
Table 13. Computational Medicine and Drug Designing Software Market Restraints
Table 14. Global Computational Medicine and Drug Designing Software Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Computational Medicine and Drug Designing Software Market Share by Players (2017-2022)
Table 16. Global Top Computational Medicine and Drug Designing Software Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Computational Medicine and Drug Designing Software as of 2021)
Table 17. Ranking of Global Top Computational Medicine and Drug Designing Software Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Computational Medicine and Drug Designing Software Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Computational Medicine and Drug Designing Software Product Solution and Service
Table 21. Date of Enter into Computational Medicine and Drug Designing Software Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Computational Medicine and Drug Designing Software Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Computational Medicine and Drug Designing Software Revenue Market Share by Type (2017-2022)
Table 25. Global Computational Medicine and Drug Designing Software Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Computational Medicine and Drug Designing Software Revenue Market Share by Type (2023-2028)
Table 27. Global Computational Medicine and Drug Designing Software Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Computational Medicine and Drug Designing Software Revenue Market Share by Application (2017-2022)
Table 29. Global Computational Medicine and Drug Designing Software Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Computational Medicine and Drug Designing Software Revenue Market Share by Application (2023-2028)
Table 31. North America Computational Medicine and Drug Designing Software Market Size by Country (2017-2022) & (US$ Million)
Table 32. North America Computational Medicine and Drug Designing Software Market Size by Country (2023-2028) & (US$ Million)
Table 33. Europe Computational Medicine and Drug Designing Software Market Size by Country (2017-2022) & (US$ Million)
Table 34. Europe Computational Medicine and Drug Designing Software Market Size by Country (2023-2028) & (US$ Million)
Table 35. Asia-Pacific Computational Medicine and Drug Designing Software Market Size by Region (2017-2022) & (US$ Million)
Table 36. Asia-Pacific Computational Medicine and Drug Designing Software Market Size by Region (2023-2028) & (US$ Million)
Table 37. Latin America Computational Medicine and Drug Designing Software Market Size by Country (2017-2022) & (US$ Million)
Table 38. Latin America Computational Medicine and Drug Designing Software Market Size by Country (2023-2028) & (US$ Million)
Table 39. Middle East & Africa Computational Medicine and Drug Designing Software Market Size by Country (2017-2022) & (US$ Million)
Table 40. Middle East & Africa Computational Medicine and Drug Designing Software Market Size by Country (2023-2028) & (US$ Million)
Table 41. Entelos Company Detail
Table 42. Entelos Business Overview
Table 43. Entelos Computational Medicine and Drug Designing Software Product
Table 44. Entelos Revenue in Computational Medicine and Drug Designing Software Business (2017-2022) & (US$ Million)
Table 45. Entelos Recent Development
Table 46. Crown Bioscience Company Detail
Table 47. Crown Bioscience Business Overview
Table 48. Crown Bioscience Computational Medicine and Drug Designing Software Product
Table 49. Crown Bioscience Revenue in Computational Medicine and Drug Designing Software Business (2017-2022) & (US$ Million)
Table 50. Crown Bioscience Recent Development
Table 51. Chemical Computing Group Company Detail
Table 52. Chemical Computing Group Business Overview
Table 53. Chemical Computing Group Computational Medicine and Drug Designing Software Product
Table 54. Chemical Computing Group Revenue in Computational Medicine and Drug Designing Software Business (2017-2022) & (US$ Million)
Table 55. Chemical Computing Group Recent Development
Table 56. Nimbus Therapeutics Company Detail
Table 57. Nimbus Therapeutics Business Overview
Table 58. Nimbus Therapeutics Computational Medicine and Drug Designing Software Product
Table 59. Nimbus Therapeutics Revenue in Computational Medicine and Drug Designing Software Business (2017-2022) & (US$ Million)
Table 60. Nimbus Therapeutics Recent Development
Table 61. Schrodinger Company Detail
Table 62. Schrodinger Business Overview
Table 63. Schrodinger Computational Medicine and Drug Designing Software Product
Table 64. Schrodinger Revenue in Computational Medicine and Drug Designing Software Business (2017-2022) & (US$ Million)
Table 65. Schrodinger Recent Development
Table 66. Dassault Systemes Company Detail
Table 67. Dassault Systemes Business Overview
Table 68. Dassault Systemes Computational Medicine and Drug Designing Software Product
Table 69. Dassault Systemes Revenue in Computational Medicine and Drug Designing Software Business (2017-2022) & (US$ Million)
Table 70. Dassault Systemes Recent Development
Table 71. Genedata Company Detail
Table 72. Genedata Business Overview
Table 73. Genedata Computational Medicine and Drug Designing Software Product
Table 74. Genedata Revenue in Computational Medicine and Drug Designing Software Business (2017-2022) & (US$ Million)
Table 75. Genedata Recent Development
Table 76. Biognos Company Detail
Table 77. Biognos Business Overview
Table 78. Biognos Computational Medicine and Drug Designing Software Product
Table 79. Biognos Revenue in Computational Medicine and Drug Designing Software Business (2017-2022) & (US$ Million)
Table 80. Biognos Recent Development
Table 81. Leadscope Company Detail
Table 82. Leadscope Business Overview
Table 83. Leadscope Computational Medicine and Drug Designing Software Product
Table 84. Leadscope Revenue in Computational Medicine and Drug Designing Software Business (2017-2022) & (US$ Million)
Table 85. Leadscope Recent Development
Table 86. Rhenovia Pharma Limited Company Detail
Table 87. Rhenovia Pharma Limited Business Overview
Table 88. Rhenovia Pharma Limited Computational Medicine and Drug Designing Software Product
Table 89. Rhenovia Pharma Limited Revenue in Computational Medicine and Drug Designing Software Business (2017-2022) & (US$ Million)
Table 90. Rhenovia Pharma Limited Recent Development
Table 91. Compugen Company Detail
Table 92. Compugen Business Overview
Table 93. Compugen Computational Medicine and Drug Designing SoftwareProduct
Table 94. Compugen Revenue in Computational Medicine and Drug Designing Software Business (2017-2022) & (US$ Million)
Table 95. Compugen Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Computational Medicine and Drug Designing Software Market Share by Type: 2021 VS 2028
Figure 2. Local Deployment Features
Figure 3. Cloud Deployment Features
Figure 4. Global Computational Medicine and Drug Designing Software Market Share by Application in 2021 & 2028
Figure 5. Drug Discovery And Development Case Studies
Figure 6. Computational Physiological Medicine Case Studies
Figure 7. Disease Modeling Case Studies
Figure 8. Medical Imaging Case Studies
Figure 9. Predictive Analysis Of Drug Targets Case Studies
Figure 10. Computational Medicine and Drug Designing Software Report Years Considered
Figure 11. Global Computational Medicine and Drug Designing Software Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Computational Medicine and Drug Designing Software Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Computational Medicine and Drug Designing Software Market Share by Region: 2021 VS 2028
Figure 14. Global Computational Medicine and Drug Designing Software Market Share by Players in 2021
Figure 15. Global Top Computational Medicine and Drug Designing Software Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Computational Medicine and Drug Designing Software as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Computational Medicine and Drug Designing Software Revenue in 2021
Figure 17. North America Computational Medicine and Drug Designing Software Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. North America Computational Medicine and Drug Designing Software Market Share by Country (2017-2028)
Figure 19. United States Computational Medicine and Drug Designing Software Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Computational Medicine and Drug Designing Software Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Computational Medicine and Drug Designing Software Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Computational Medicine and Drug Designing Software Market Share by Country (2017-2028)
Figure 23. Germany Computational Medicine and Drug Designing Software Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. France Computational Medicine and Drug Designing Software Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. U.K. Computational Medicine and Drug Designing Software Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Italy Computational Medicine and Drug Designing Software Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Russia Computational Medicine and Drug Designing Software Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Nordic Countries Computational Medicine and Drug Designing Software Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Computational Medicine and Drug Designing Software Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Computational Medicine and Drug Designing Software Market Share by Region (2017-2028)
Figure 31. China Computational Medicine and Drug Designing Software Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Japan Computational Medicine and Drug Designing Software Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. South Korea Computational Medicine and Drug Designing Software Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Southeast Asia Computational Medicine and Drug Designing Software Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. India Computational Medicine and Drug Designing Software Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Australia Computational Medicine and Drug Designing Software Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Latin America Computational Medicine and Drug Designing Software Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Latin America Computational Medicine and Drug Designing Software Market Share by Country (2017-2028)
Figure 39. Mexico Computational Medicine and Drug Designing Software Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Brazil Computational Medicine and Drug Designing Software Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Middle East & Africa Computational Medicine and Drug Designing Software Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Middle East & Africa Computational Medicine and Drug Designing Software Market Share by Country (2017-2028)
Figure 43. Turkey Computational Medicine and Drug Designing Software Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Saudi Arabia Computational Medicine and Drug Designing Software Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Entelos Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2017-2022)
Figure 46. Crown Bioscience Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2017-2022)
Figure 47. Chemical Computing Group Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2017-2022)
Figure 48. Nimbus Therapeutics Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2017-2022)
Figure 49. Schrodinger Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2017-2022)
Figure 50. Dassault Systemes Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2017-2022)
Figure 51. Genedata Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2017-2022)
Figure 52. Biognos Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2017-2022)
Figure 53. Leadscope Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2017-2022)
Figure 54. Rhenovia Pharma Limited Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2017-2022)
Figure 55. Compugen Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2017-2022)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
